Innocoll Holdings plc to Present at the Piper Jaffray Annual Healthcare Conference
23. November 2016 08:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Third Quarter 2016 Financial and Operating Results and Provides Corporate Update
22. November 2016 08:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll to Report Third Quarter 2016 Financial Results and Host Webcast and Conference Call on November 22, 2016
15. November 2016 08:30 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc to Present at the Stifel 2016 Healthcare Conference
14. November 2016 08:30 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Second Quarter 2016 Financial and Operating Results and Provides Corporate Update
17. August 2016 08:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 17, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll to Report Second Quarter 2016 Financial Results and Host Webcast and Conference Call on August 17, 2016
11. August 2016 16:01 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
06. Juli 2016 09:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces the Completion of Enrollment in Two Pivotal Phase 3 Clinical Trials of COGENZIA for the Treatment of Diabetic Foot Infections
23. Juni 2016 09:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference
16. Juni 2016 09:20 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Proposed Public Offering of Ordinary Shares
13. Juni 2016 16:15 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 13, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...